INSP250117P330000
- 0.00
- 0.000.00%
Inspire Medical Systems Newsroom
Inspire Medical Systems, Inc. to Present at 43rd Annual J.P. Morgan Healthcare Conference
Hold Rating on Inspire Medical Systems Amid FDA Approval of Tirzepatide for OSA
The Price Is Right For Inspire Medical Systems, Inc. (NYSE:INSP)
Inspire Medical Systems' (NYSE:INSP) Returns On Capital Are Heading Higher
Express News | Resmed Shares Down 4% and Inspire Medical Systems Shares Fall 2.7% in Early Trading
Express News | Shares of Sleep Apnea Device Makers Resmed and Inspire Medical Systems Fall After US FDA Approves Eli Lilly's Weight-Loss Drug to Treat Sleep Apnea
Coupa Announces Inspire May 12-15 and Inspire World Tour Roadshow
Wells Fargo Maintains Inspire Medical Systems(INSP.US) With Hold Rating, Maintains Target Price $198
Inspire Medical Systems: Balancing Growth Prospects and Market Challenges – A Hold Rating by Larry Biegelsen
Presidio Medical Announces Appointment of Richard J. Buchholz to Join Its Board of Directors
Leerink Partners Sticks to Their Hold Rating for Inspire Medical Systems (INSP)
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Express News | Inspire Medical Systems Inc : Leerink Partners Cuts Target Price to $193 From $197
Sector Update: Health Care Stocks Advance Late Afternoon
Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade
BofA Securities Upgrades Inspire Medical Systems(INSP.US) to Buy Rating, Raises Target Price to $255
Returns At Inspire Medical Systems (NYSE:INSP) Are On The Way Up
Inspire Medical Systems Maintains Strong Market Position Amidst LIVN's Aura6000 Uncertainties
Lake Street Maintains Inspire Medical Systems(INSP.US) With Buy Rating, Maintains Target Price $270
Inspire Medical Accelerates $75M Stock Repurchase as Part of $150M Buyback Plan